CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity

Jian Ma,Dianyun Ren,Zixi Wang,Wei Li,Lei Li,Tianjie Liu,Qi Ye,Yuzeshi Lei,Yanlin Jian,Bohan Ma,Yizeng Fan,Jing Liu,Yang Gao,Xin Jin,Haojie Huang,Lei Li

DOI: https://doi.org/10.1126/sciadv.adk8908

IF: 13.6

2024-05-24

Science Advances

Abstract:DNA replication is a vulnerable cellular process, and its deregulation leads to genomic instability. Here, we demonstrate that chromobox protein homolog 3 (CBX3) binds replication protein A 32-kDa subunit (RPA2) and regulates RPA2 retention at stalled replication forks. CBX3 is recruited to stalled replication forks by RPA2 and inhibits ring finger and WD repeat domain 3 (RFWD3)–facilitated replication restart. Phosphorylation of CBX3 at serine-95 by casein kinase 2 (CK2) kinase augments cadherin 1 (CDH1)–mediated CBX3 degradation and RPA2 dynamics at stalled replication forks, which permits replication fork restart. Increased expression of CBX3 due to gene amplification or CK2 inhibitor treatment sensitizes prostate cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors while inducing replication stress and DNA damage. Our work reveals CBX3 as a key regulator of RPA2 function and DNA replication, suggesting that CBX3 could serve as an indicator for targeted therapy of cancer using PARP inhibitors.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about **the role of CBX3 in DNA replication stalling and its impact on the sensitivity to PARP inhibitors**. Specifically, the study focuses on the following aspects:

1. **The interaction between CBX3 and RPA2**: Explore how CBX3 affects the retention and function of RPA2 on stalled replication forks by binding to RPA2.

2. **The inhibitory effect of CBX3 on RFWD3 - mediated RPA2 ubiquitination and unloading**: Study how CBX3 prevents RFWD3 from ubiquitinating RPA2, thereby affecting the dynamic changes of RPA2 on stalled replication forks.

3. **The cell - cycle regulation of CBX3**: Explore the fluctuations in the CBX3 protein level during the cell cycle, especially its peak in the G2 - M phase and the decline in the G1 - S phase, and the role of CDH1 in this process.

4. **The regulation of CK2 on CBX3 phosphorylation**: Study how the phosphorylation of CBX3 by CK2 at the Ser - 95 site enhances CDH1 - mediated CBX3 degradation, and further affects the dynamic changes of RPA2 on stalled replication forks.

5. **The impact of CBX3 expression on replication fork restart and chromosomal instability**: Explore how high - expression of CBX3 restricts replication fork restart, promotes chromosomal instability, and leads to an increase in DNA damage.

6. **The relationship between CBX3 expression and the sensitivity to PARP inhibitors**: Study how high - expression of CBX3 makes prostate cancer cells more sensitive to PARP inhibitors, and thus may become a potential biomarker for PARP inhibitor treatment.

Through these studies, the authors hope to reveal the crucial role of CBX3 in DNA replication stalling and repair, and provide new targets and strategies for cancer treatment.